IRAZAGE Trademark

Trademark Overview


On Thursday, December 13, 2018, a trademark application was filed for IRAZAGE with the United States Patent and Trademark Office. The USPTO has given the IRAZAGE trademark a serial number of 79249996. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, October 21, 2022. This trademark is owned by NOVARTIS AG. The IRAZAGE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal pharmaceutical preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparat...
irazage

General Information


Serial Number79249996
Word MarkIRAZAGE
Filing DateThursday, December 13, 2018
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, October 21, 2022
Registration Number5816206
Registration DateTuesday, July 30, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal pharmaceutical preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, October 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Sunday, November 6, 2022NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, November 6, 2022DEATH OF INTERNATIONAL REGISTRATION
Friday, December 13, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 21, 2019FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 21, 2019FINAL DISPOSITION PROCESSED
Wednesday, October 30, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 30, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 1, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 1, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 28, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 28, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 8, 2019REFUSAL PROCESSED BY IB
Tuesday, February 19, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 19, 2019REFUSAL PROCESSED BY MPU
Thursday, February 7, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, February 6, 2019NON-FINAL ACTION WRITTEN
Tuesday, February 5, 2019ASSIGNED TO EXAMINER
Saturday, February 2, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, January 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, January 28, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 24, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB